Public Health and Legal Implications of Treatment Flexibilities for Substance Use Treatment During and After the COVID-19 Pandemic
June 16, 2021 at 2:00 – 3:00 PM EDT The webinar will provide the attorney general community and other stakeholders with an update on increased flexibilities in treatment delivery (e.g., telehealth services) for substance use disorder treatment during and beyond the COVID-19 pandemic, highlighting specific policy and legal considerations. Specifically, the webinar will provide the…
Attorneys General Urge Congress to Support Bipartisan School Violence Prevention Bill
Washington, D.C. — The National Association of Attorneys General (NAAG) is urging Congress to pass the EAGLES Act, a national program to prevent targeted school violence. The legislation is named for the Marjory Stoneman Douglas High School Eagles and would expand the U.S. Secret Service’s National Threat Assessment Center (NTAC) with a greater focus on…
COVID-19 Vaccines and Effective Communications Strategies
The U.S. distribution of safe and efficacious vaccines to prevent COVID-19 has increased exponentially since December 2020. The average daily rates of vaccines administered in the U.S. has reached 3.3 million in April. On April 14, the U.S. reached more than 194.8 million total doses administered with 76.7 million persons (23.1% of the total U.S….
Attorney General Journal Article Submission Guidelines
NAAG is seeking articles from the attorney general community and academia to publish in the Attorney General Journal. Writing for the Attorney General Journal offers a chance to share your legal knowledge and experience with readers in the attorney general community, government lawyers, and audiences, while also raising the profile of the excellent work done in attorney general…
Bipartisan Coalition of Attorneys General Fight Unlawful Sales of Fake COVID-19 Vaccination Cards
Washington, D.C. — The National Association of Attorneys General (NAAG) today called on Twitter, eBay, and Shopify to act immediately to prevent people from selling fraudulent CDC vaccination cards on their platforms. The bipartisan coalition, led by North Carolina Attorney General Josh Stein and Tennessee Attorney General Herbert H. Slatery III, raised concerns about the…
2020 Annual Report
The 2020 NAAG Annual Report provides a summary of the organization’s activity and highlights some of the many accomplishments of NAAG members and staff during the 2020 fiscal year.
We’re Hiring! How to Create an Effective Job Description to Attract Talent
This webinar is hosted by the NAGTRI Center for Leadership Development. Tuesday, April 20 at 2:00 p.m. – 3:00 p.m. ET This interactive webinar offers information on developing and updating position descriptions as tools that support overall performance management. The presenter will: Address the value and purpose of job descriptions and essential content. Suggest best practices…
The Rise of Hate and its Deadly Consequences
On Wednesday, April 14, 2021, NAAG President and District of Columbia Attorney General Karl A. Racine will host a webinar centered on the impact of hate. The webinar will examine how attorneys general can advocate for and implement legal solutions to combat and prevent hate and better support victims, survivors, and their families. Panelists will…
Current Status of COVID-19 Vaccines Rollout Nationwide: March 2021 Update for the Attorney General Community
The distribution of three safe and efficacious vaccines to prevent COVID-19 has continued to ramp up both globally and domestically. Here in the U.S., average daily rates of vaccines administered has increased from 1.5 million at the end of February to close to 2.5 million in March. On March 24, the U.S. reached over 130…
The Defense Production Act and Implications for the COVID-19 Vaccine Rollout
Since the U.S. Food and Drug Administration (FDA) issued authorizations for the Pfizer-BioNTech and Moderna vaccines to prevent COVID-19, millions of doses of both of these safe and effective vaccines have been administered throughout the United States. On February 27, the FDA authorized a third vaccine from Janssen, a subsidiary of Johnson & Johnson. An…
